CY
CYBO.LSE VanEck Bionic Engineering UCITS ETF A Acc
- USD
No recent price
- Total assets
- 4.75M
- Expense ratio
- 0.54%
- Dividend yield
- -
- 1-year return
- -2.63%
- Holdings
- 24
- Since
- 2022
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does CYBO.LSE invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (76.4%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (76.9%)
- Top 3 holdings: 31.7% of the fund
Asset allocation
- US stocks 76.4%
- Non-US stocks 19.7%
- Cash 0.1%
Top holdings
- Intuitive Surgical Inc 11.39%
- Edwards Lifesciences Corp 10.45%
- Stryker Corporation 9.91%
- Medtronic PLC 9.76%
- DexCom Inc 6.15%
VanEck Bionic Engineering UCITS ETF A Acc performance
Sharpe ratio 0.15- This year
- -4.43%
- 1 year
- -2.63%
- 3 years
- +5.65%
- 5 years
- 0.00%
Volatility 18.0% over 1 year and 18.6% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
CYBO.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
VanEck Bionic Engineering UCITS ETF A Acc top holdings
68.6% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Intuitive Surgical Inc ISRG.US | Healthcare | United States | 11.39% |
| Edwards Lifesciences Corp EW.US | Healthcare | United States | 10.45% |
| Stryker Corporation SYK.US | Healthcare | United States | 9.91% |
| Medtronic PLC MDT.US | Healthcare | United States | 9.76% |
| DexCom Inc DXCM.US | Healthcare | United States | 6.15% |
| Sonova H Ag SOON.SW | Healthcare | Switzerland | 5.01% |
| Straumann Holding AG STMN.SW | Healthcare | Switzerland | 4.27% |
| Glaukos Corp GKOS.US | Healthcare | United States | 4.22% |
| Zimmer Biomet Holdings Inc ZBH.US | Healthcare | United States | 3.89% |
| Smith & Nephew SNATS Inc SNN.US | Healthcare | United States | 3.53% |
The 10 largest of 24 holdings.
CYBO.LSE sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
CYBO.LSE regional exposure
- North America76.9%
- Europe Developed13.4%
- United Kingdom3.5%
- Australasia2.9%
- Asia Emerging0.1%
Share of the stocks in the fund.
Company size
Average market cap 23.0B- Big cap32.9%
- Medium cap39.0%
- Small cap12.4%
- Micro cap14.1%
VanEck Bionic Engineering UCITS ETF A Acc fund profile
- Fund name
- VanEck Bionic Engineering UCITS ETF A Acc
- Ticker
- CYBO.LSE
- Exchange
- London Exchange
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Dec 2, 2022
- Trading currency
- USD
- Expense ratio
- 0.54%